Cobblestone Capital Advisors LLC NY Has $1.75 Million Stock Holdings in Stryker Corporation $SYK

Cobblestone Capital Advisors LLC NY trimmed its holdings in shares of Stryker Corporation (NYSE:SYK) by 2.3% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 4,424 shares of the medical technology company’s stock after selling 104 shares during the period. Cobblestone Capital Advisors LLC NY’s holdings in Stryker were worth $1,750,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of SYK. Mid American Wealth Advisory Group Inc. acquired a new position in shares of Stryker during the 2nd quarter worth about $26,000. Sachetta LLC boosted its stake in shares of Stryker by 58.7% during the 2nd quarter. Sachetta LLC now owns 73 shares of the medical technology company’s stock worth $29,000 after buying an additional 27 shares during the last quarter. Goodman Advisory Group LLC acquired a new position in shares of Stryker during the 1st quarter worth about $32,000. Ridgewood Investments LLC boosted its stake in shares of Stryker by 48.4% during the 2nd quarter. Ridgewood Investments LLC now owns 92 shares of the medical technology company’s stock worth $36,000 after buying an additional 30 shares during the last quarter. Finally, Ransom Advisory Ltd acquired a new stake in Stryker in the 1st quarter valued at about $37,000. 77.09% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Stryker

In other news, insider Viju Menon sold 500 shares of the firm’s stock in a transaction that occurred on Monday, August 25th. The shares were sold at an average price of $390.61, for a total transaction of $195,305.00. Following the transaction, the insider directly owned 12,511 shares of the company’s stock, valued at approximately $4,886,921.71. This trade represents a 3.84% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Ronda E. Stryker sold 200,000 shares of the firm’s stock in a transaction that occurred on Wednesday, August 6th. The stock was sold at an average price of $376.45, for a total transaction of $75,290,000.00. Following the transaction, the director directly owned 3,222,108 shares in the company, valued at $1,212,962,556.60. This represents a 5.84% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 5.20% of the company’s stock.

Analyst Ratings Changes

SYK has been the subject of several recent analyst reports. UBS Group set a $408.00 target price on shares of Stryker in a research note on Monday, October 13th. BTIG Research raised their target price on shares of Stryker from $407.00 to $408.00 and gave the company a “buy” rating in a research note on Monday, October 13th. Weiss Ratings reiterated a “buy (b-)” rating on shares of Stryker in a research note on Friday. Truist Financial cut their target price on shares of Stryker from $415.00 to $407.00 and set a “hold” rating for the company in a research note on Wednesday, October 15th. Finally, Barclays raised their target price on shares of Stryker from $443.00 to $453.00 and gave the company an “overweight” rating in a research note on Wednesday. Fifteen analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat, Stryker currently has a consensus rating of “Moderate Buy” and an average target price of $432.24.

Stryker Trading Down 0.3%

Shares of SYK stock opened at $381.86 on Monday. The firm has a 50 day moving average price of $379.84 and a two-hundred day moving average price of $380.14. The company has a quick ratio of 1.06, a current ratio of 1.78 and a debt-to-equity ratio of 0.70. The company has a market capitalization of $145.99 billion, a PE ratio of 50.58, a price-to-earnings-growth ratio of 2.75 and a beta of 0.94. Stryker Corporation has a 12-month low of $329.16 and a 12-month high of $406.19.

Stryker (NYSE:SYK) last issued its quarterly earnings data on Thursday, July 31st. The medical technology company reported $3.13 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.07 by $0.06. The firm had revenue of $6.02 billion during the quarter, compared to the consensus estimate of $5.92 billion. Stryker had a net margin of 12.25% and a return on equity of 23.94%. The business’s revenue for the quarter was up 11.1% compared to the same quarter last year. During the same period last year, the business posted $2.81 earnings per share. Stryker has set its FY 2025 guidance at 13.400-13.600 EPS. As a group, analysts predict that Stryker Corporation will post 13.47 earnings per share for the current year.

Stryker Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Tuesday, September 30th will be given a dividend of $0.84 per share. The ex-dividend date is Tuesday, September 30th. This represents a $3.36 annualized dividend and a yield of 0.9%. Stryker’s dividend payout ratio (DPR) is 44.50%.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.